臨床試験

CIRSE Registry for SIR-Spheres Therapy

NCT: NCT02305459 · COMPLETED

NCT識別子NCT02305459

ステータスCOMPLETED

完了2020-01-01

SponsorCardiovascular and Interventional Radiological Society of Europe (OTHER)

First posted2014-12-02

Last updated2026-05-14

概要

The administration of SIR-Spheres microspheres (yttrium-90 resin microspheres) is a form of selective internal radiation therapy (SIRT) for the treatment of patients with primary and secondary liver tumours. The primary objective is to observe the real-life clinical application of radioembolisation with SIR-Spheres and the impact of the treatment in clinical practice. Secondary objectives are to observe safety and effectiveness of SIR-Spheres treatment in terms of adverse events, Overall Survival (OS), Progression-free survival (PFS), technical considerations, liver PFS and Quality of Life (QoL) + subgroup analyses

公式ソース

ClinicalTrials.govで見る →

データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。